Featured Research

from universities, journals, and other organizations

Targeting Tumor Behavior May Lead To New Liver Cancer Drugs

Date:
June 20, 2009
Source:
Ohio State University Medical Center
Summary:
Cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that target multiple genes simultaneously. The researchers were seeking agents that might reverse gene changes in invasive liver cancer cells and block the spread of the disease in the body. The strategy is a new way to find potentially useful anti-cancer agents because it identifies agents that strike multiple targets involved in a particular stage of disease development.

Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.

The researchers wanted to find agents that might reverse the gene changes associated with invasive liver cancer and perhaps stop liver tumors from spreading in the body. Such therapy could greatly improve patient survival, the researchers say.

The findings are published online in the journal Cancer.

“This is an exciting new way to find potentially useful anti-cancer agents,” says principal investigator Dr. Tushar Patel, director of hepatology and a researcher with Ohio State’s Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute.

“For nearly two decades, cancer drug discovery has sought agents that block a single molecular target or pathway,” he says. “Our approach identifies agents that could potentially block tumor progression by striking multiple genes that are associated with a particular cancer-related behavior.”

New drugs for liver cancer are needed because the disease is widespread worldwide. The most common type of liver cancer, hepatocellular carcinoma, causes 630,000 deaths every year worldwide, and the incidence is rising in many countries, including the United States.

Only one drug is presently approved for treating advanced liver cancer, Patel says. He notes that several new agents are in development for the disease, but each affects just one or another of the many processes that are altered in liver cancer cells.

“We believe that targeting a certain type of tumor behavior might be helpful for liver cancer because many different biochemical pathways in tumor cells can be involved. Most targeted agents affect only one pathway, so a combination of drugs may be needed. Alternatively, new agents that hit multiple targets simultaneously could be used,” he says.

Patel and his colleagues began their study by identifying the gene changes present in liver cancers that had invaded neighboring blood vessels.

The researchers then looked for agents that could reverse these changes as a group. They did this using a database called the connectivity map, a collection of data sets that offers a way to compare gene changes caused by a disease with gene changes caused by different chemicals or drugs.

“We queried the gene changes present in invasive liver cancer cells against the connectivity map and looked for compounds that had an opposite effect on these changes,” Patel says. “If genes ‘A, B and C’ were increased in our tumor cells, we wanted to find an agent that decreased genes ‘A, B and C’,” he says.

Their search identified two compounds: Resveratol, a component of red wine that recently and coincidentally was shown by others to inhibit the ability of liver cancer cells to invade tissues and metastasize, and 17-allylamino-geldanamycin (17-AAG), which has shown anticancer activity in some solid tumors but has not been tested in liver cancer.

Last, the researchers used laboratory tests to verify that the two compounds actually did alter the invasive ability of liver cancer cells.

“This approach is exciting because it can be applied to any well-defined disease behavior,” Patel says. “It might also improve the approach to drug discovery and design if some agents were modified to select for a particular genomic profile rather than a single chemical target.

“Overall,” he says, “this could be a more relevant way of looking at cancer because we want to block certain disease changes and specific effects such as invasion, metastasis or chemotherapy resistance.”

Other Ohio State researchers involved in this study were Chiara Braconi, Erica Swenson, Lyudmyla Khrapenko and Nianyuan Huang.


Story Source:

The above story is based on materials provided by Ohio State University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University Medical Center. "Targeting Tumor Behavior May Lead To New Liver Cancer Drugs." ScienceDaily. ScienceDaily, 20 June 2009. <www.sciencedaily.com/releases/2009/06/090618124952.htm>.
Ohio State University Medical Center. (2009, June 20). Targeting Tumor Behavior May Lead To New Liver Cancer Drugs. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2009/06/090618124952.htm
Ohio State University Medical Center. "Targeting Tumor Behavior May Lead To New Liver Cancer Drugs." ScienceDaily. www.sciencedaily.com/releases/2009/06/090618124952.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins